J
Judith C. Shlay
Researcher at University of Colorado Denver
Publications - 68
Citations - 2386
Judith C. Shlay is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Population & Sexually transmitted disease. The author has an hindex of 24, co-authored 64 publications receiving 2245 citations. Previous affiliations of Judith C. Shlay include Anschutz Medical Campus & United States Public Health Service.
Papers
More filters
Journal ArticleDOI
Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral Neuropathy: A Randomized Controlled Trial
Judith C. Shlay,Kathryn Chaloner,Mitchell B. Max,Bob Flaws,Patricia Reichelderfer,Deborah Wentworth,Shauna Hillman,Barbara Brizz,David L. Cohn +8 more
TL;DR: Neither acupuncture nor amitriptyline was more effective than placebo in relieving pain caused by HIV-related peripheral neuropathy in HIV-infected patients.
Journal ArticleDOI
Continuous antiretroviral therapy decreases bone mineral density.
Birgit Grund,Grace Peng,Cynthia L. Gibert,Jennifer F Hoy,Rachel Isaksson,Judith C. Shlay,Esteban Martínez,Peter Reiss,Fehmida Visnegarwala,Andrew Carr +9 more
TL;DR: Continuous ART is associated with decline in BMD and possibly more fractures relative to intermittent, CD4 cell count-guided ART and no consistent drug-specific association with BMD decline was found.
Journal ArticleDOI
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.
Edwina J. Wright,Edwina J. Wright,Edwina J. Wright,Birgit Grund,Kevin Robertson,Bruce J. Brew,Bruce J. Brew,Mollie P. Roediger,Margaret P Bain,Fraser Drummond,Michael J. Vjecha,Jennifer F Hoy,Jennifer F Hoy,C Miller,A C Penalva de Oliveira,W. Pumpradit,Judith C. Shlay,Wafaa El-Sadr,Richard W. Price +18 more
TL;DR: In this HIV-positive population with high CD4 cell counts, neurocognitive impairment was associated with prior CVD, hypertension, and hypercholesterolemia, but not conventional HAD risk factors.
Journal ArticleDOI
Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003–2005
S. Deblina Datta,Laura A. Koutsky,Sylvie Ratelle,Elizabeth R. Unger,Judith C. Shlay,Tracie McClain,Beth Weaver,Peter R. Kerndt,Jonathan M. Zenilman,Michael E. Hagensee,Cristen J. Suhr,Hillard Weinstock +11 more
TL;DR: Some cervical cancer screening programs test for human papillomavirus (HPV) only after abnormal Papanicolaou (Pap) test results, whereas others perform both tests routinely and repeat testing if ei...
Journal ArticleDOI
Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine.
Judith C. Shlay,Fehmida Visnegarwala,Glenn E. Bartsch,Jack Wang,Grace Peng,Wafaa El-Sadr,Cynthia L. Gibert,Donald P. Kotler,Carl Grunfeld,Subhasree Raghavan +9 more
TL;DR: Comparisons of body composition and metabolic changes among antiretroviral-naive patients randomly assigned to didanosine and stavudine- (ddI + d4T) vs. abacavir and lamivudine - (ABC + 3TC) containing regimens were assessed in an ongoing multicenter randomized trial.